Bruno Carlos
Sangro Gómez-Acebo
Catedrático de Universidad
University of Tübingen
Tubinga, AlemaniaPublicacions en col·laboració amb investigadors/es de University of Tübingen (4)
2022
-
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma
Clinical Cancer Research, Vol. 28, Núm. 12, pp. 2555-2566
-
Prognostic Factors for Effectiveness Outcomes After Transarterial Radioembolization in Metastatic Colorectal Cancer: Results From the Multicentre Observational Study CIRT
Clinical Colorectal Cancer, Vol. 21, Núm. 4, pp. 285-296
2019
-
Corrigendum to “New vaccination strategies in liver cancer” [Cytokine Growth Factor Rev. 36 (2017) 125–129](S1359610117301089)(10.1016/j.cytogfr.2017.06.010)
Cytokine and Growth Factor Reviews
-
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
Genome Medicine, Vol. 11, Núm. 1